Researchers in the United States have developed an artificial intelligence (AI) tool designed to predict cancer patients' survival chances by analyzing facial images. The technology, named FaceSurvival, aims to assist physicians in determining the appropriate intensity of treatment by identifying patients at higher risk of mortality.

This AI system builds upon previous findings indicating that cancer patients who appear older than their chronological age tend to have poorer survival outcomes. Unlike earlier methods which estimated a patient’s biological age, FaceSurvival detects nuanced facial features linked to survival probabilities, potentially uncovering signs not readily visible to the human eye.

The study detailing the development and validation of FaceSurvival was published in The Lancet Digital Health journal. Researchers suggest that this tool could offer a more objective measure to complement the informal ‘eyeball test’—a common clinical practice where doctors assess a patient’s general health and frailty based on visual observation.

By providing insights from a simple facial photograph, the technology could streamline pre-treatment evaluations, helping oncologists decide which patients might tolerate aggressive therapies and which may benefit from less intensive approaches. The development of FaceSurvival represents a step toward integrating AI-driven biomarkers into routine clinical assessments, potentially improving personalized care for cancer patients.